share_log

4: Statement of changes in beneficial ownership of securities-Director SCANNON PATRICK J MD PHD

4: Statement of changes in beneficial ownership of securities-Director SCANNON PATRICK J MD PHD

4:持股变动声明-董事 SCANNON PATRICK J MD PHD
美股sec公告 ·  05/13 16:22
Moomoo AI 已提取核心信息
Patrick J. Scannon, MD, PhD, reported a transaction related to Cassava Sciences Inc (SAVA) stock on May 9, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to monitor the company's filings for further information regarding this transaction.
Patrick J. Scannon, MD, PhD, reported a transaction related to Cassava Sciences Inc (SAVA) stock on May 9, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to monitor the company's filings for further information regarding this transaction.
医学博士、帕特里克·斯坎农于2024年5月9日报告了一笔与木薯科学公司(SAVA)股票相关的交易。公告中未披露交易的具体细节,包括行动类型、状态、所涉股份数量、股票性质、交易价格和交易后的持股情况。建议投资者关注公司的申报情况,以获取有关该交易的更多信息。
医学博士、帕特里克·斯坎农于2024年5月9日报告了一笔与木薯科学公司(SAVA)股票相关的交易。公告中未披露交易的具体细节,包括行动类型、状态、所涉股份数量、股票性质、交易价格和交易后的持股情况。建议投资者关注公司的申报情况,以获取有关该交易的更多信息。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息